Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Mycobacterium tuberculosis (Mtb) respiratory chain and cell membrane constitute a complex system of enzymes and structural components essential for the pathogen's survival, particularly during latent or persistent phases. The respiratory chain includes key complexes such as NADH dehydrogenase (NDH-1 and NDH-2), the cytochrome bc1-aa3 oxidase complex, and ATP synthase, which together generate the proton motive force required for ATP production (Cook et al., 2014). The mycobacterial membrane is uniquely characterized by a thick layer of mycolic acids, providing a robust physical barrier and anchoring various metabolic proteins (Kundu et al., 2017). This system is a major focus of modern antitubercular drug development; for instance, Bedaquiline inhibits the c-subunit of ATP synthase, while Telacebec targets the QcrB subunit of the cytochrome bcc complex (Andries et al., 2005; Pethe et al., 2013). By disrupting energy production and membrane stability, these drugs can effectively kill both actively replicating and non-replicating bacteria. However, because these processes are fundamental to life, therapeutic agents must be highly selective for mycobacterial proteins over human mitochondrial counterparts to minimize systemic toxicity (Bald et al., 2017).
Inhibition of ATP synthase, blockade of the cytochrome bcc complex, inhibition of NADH dehydrogenase, and disruption of mycolic acid synthesis or membrane potential.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mycobacterium tuberculosis respiratory chain and cell membrane (Mtb respiratory chain/membrane).